Do structural properties explain the anticonvulsant activity of valproate metabolites?: A QSAR analysis

被引:17
作者
Bello-Ramírez, AM
Carreón-Garabito, BY
Nava-Ocampo, AA
机构
[1] Univ Autonoma Estado Morelos, Ctr Invest Quim, Cuernavaca, Morelos, Mexico
[2] Hosp Infantil Mexico Dr Federico Gomez, Dept Anesthesia & Resp Therapy, Secretaria Salud, Mexico City, DF, Mexico
[3] Ctr Med Nacl Siglo XXI, Hosp Especialidades, Unit Med Res Pharmacol, IMSS, Mexico City, DF, Mexico
关键词
QSAR analysis; biologic activity explanation; anticonvulsant drugs;
D O I
10.1046/j.1528-1157.2002.365011.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: Differences in potency among valproate (VPA) metabolites could be explained by structural properties. Therefore, a quantitative structure-activity relation (QSAR) analysis was performed to study the relation between structural parameters and the effect of the following VPA metabolites: 4-en-VPA, 2-en-VPA, 3-en-VPA, 2,4'-dien-VPA, 4,4'-dien-VPA, 4-hydroxy-VPA, 3-ceto-VPA, 3-hydroxy-VPA, 5-hydroxy-VPA, and propylglutaric acid. Methods: By using the CAChe program package for biomolecules (Oxford Molecular, Ltd), we performed molecular modeling. The anticonvulsant activity determined on the threshold for maximal electroconvulsions in mice was obtained from a study of Loscher and Nau. Structural parameters were compared between metabolites with a double bond and metabolites with oxygen at either side chain (unpaired Student's t test). A single linear regression analysis between each structural parameter and the relative anticonvulsant potency was also performed. Results: Similar parameters were found between the cis and trans and R and S isomers. Biologic activity and most of the structural parameters were significantly different between metabolites with a double bond and metabolites with oxygen at either side chain. Activity was directly related to log P-oct (r(2) = 0.77) and to reactivity parameters and was inversely related to stability parameters and to molecular weight and surface. The most potent metabolites had a log P-oct value of higher than 2 units. Conclusions: Similar data were identified between cis and trans, and R and S isomers of VPA metabolites. Anticonvulsant activity was mainly related to log P-oct, probably reflecting the ability of VPA metabolites to cross the blood-brain barrier.
引用
收藏
页码:475 / 481
页数:7
相关论文
共 25 条
[1]   Hematologic toxicity of sodium valproate [J].
Acharya, S ;
Bussel, JB .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2000, 22 (01) :62-65
[2]  
Carey F., 1990, ADV ORGANIC CHEM A, P9
[3]   Valproate metabolites in the rat brain -: regional distribution in various brain areas [J].
Darius, J ;
Meyer, FP ;
Bergsträsser, E ;
Ebermann, E ;
Andreas, K .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1999, 24 (01) :97-104
[4]  
Detournay B, 2000, THERAPIE, V55, P137
[5]  
Dodson W E, 1994, J Child Neurol, V9 Suppl 2, P1
[6]  
Dreifuss F E, 1988, Am J Med, V84, P34, DOI 10.1016/0002-9343(88)90055-1
[7]  
ELIEL EL, 1994, STEREOCHEMISTRY ORGA, P201
[8]   VALPROATE METABOLITES IN SERUM AND URINE DURING ANTIEPILEPTIC THERAPY IN CHILDREN WITH INFANTILE SPASMS - ABNORMAL METABOLITE PATTERN ASSOCIATED WITH REVERSIBLE HEPATOTOXICITY [J].
FISHER, E ;
SIEMES, H ;
PUND, R ;
WITTFOHT, W ;
NAU, H .
EPILEPSIA, 1992, 33 (01) :165-171
[9]   Molecular factors influencing drug transfer across the blood-brain barrier [J].
Gratton, JA ;
Abraham, MH ;
Bradbury, MW ;
Chadha, HS .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (12) :1211-1216
[10]   QSAR STUDIES ON DRUGS ACTING AT THE CENTRAL NERVOUS-SYSTEM [J].
GUPTA, SP .
CHEMICAL REVIEWS, 1989, 89 (08) :1765-1800